Skip to main content

Advertisement

SpringerLink
Log in

Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus erythematosus, are associated with an increased risk of coronary artery disease (CAD) as a result of accelerated atherosclerosis. However, the data on CAD risk of polymyalgia rheumatica (PMR), one of the most common chronic inflammatory disorders in older adults, remain unclear due to limited number of epidemiological studies. To further investigate this possible association, this systematic review and meta-analysis of observational studies was performed to compare the risk of CAD in patients with PMR versus subjects without it. Published studies indexed in MEDLINE and EMBASE were searched from inception to April 2016 using the terms “polymyalgia rheumatica” combined with the terms for CAD. The inclusion criteria were: (1) observational studies published as original studies to evaluate the risk of CAD among patients with PMR; (2) published odds ratios, relative risk or hazard ratio or standardized incidence ratio with 95 % confidence intervals (CI) in the studies; and (3) subjects without PMR were used as comparators in cohort studies and cross-sectional studies, while subjects without CAD were used as comparators in case–control studies. Point estimates and standard errors were extracted from individual studies and were combined by the generic inverse variance method of DerSimonian and Laird. Four studies with 34,569 patients with PMR were identified and included in this meta-analysis. The pooled risk ratio of CAD in patients with PMR was 1.72 (95 % CI 1.21–2.45). The statistical heterogeneity of this meta-analysis was high with an I 2 of 97 %.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Smeeth L, Cook C, Hall AJ (2006) Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis 65:1093–1098

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Borchers AT, Gershwin ME (2012) Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev 11:A544–A554

    Article  PubMed  Google Scholar 

  3. Ungprasert P, Charoenpong P, Ratanasrimetha P et al (2014) Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis. Clin Rheumatol 33:1099–1104

    Article  PubMed  Google Scholar 

  4. Ungprasert P, Suksaranjit P, Spanuchart I et al (2014) Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum 44:63–67

    Article  PubMed  Google Scholar 

  5. Bessant R, Hingorani A, Patel L et al (2004) Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford) 43:924–929

    Article  CAS  Google Scholar 

  6. Maradit-Kremers H, Nicola PJ, Crowson CS et al (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732

    Article  PubMed  Google Scholar 

  7. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868–874

    Article  CAS  PubMed  Google Scholar 

  8. Montecucco F, Mach F (2009) Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology (Oxford) 48:11–22

    Article  CAS  Google Scholar 

  9. Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605

    Article  PubMed  Google Scholar 

  10. Herzog R, Alvarez-Pasquin MJ, Diaz C et al (2013) Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health 13:154

    Article  PubMed  PubMed Central  Google Scholar 

  11. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trial 7:177–188

    Article  CAS  Google Scholar 

  12. Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 2003(327):557–560

    Article  Google Scholar 

  13. Kremers HM, Reinalda MS, Crowson CS et al (2005) Direct medical cost of polymyalgia rheumatica. Arthritis Rheum 53:578–584

    Article  PubMed  Google Scholar 

  14. Zoller B, Li X, Sundquist J et al (2012) Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS One 7:e33442

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hancock AT, Mallen CD, Muller S et al (2014) Risk of vascular events in patients with polymyalgia rheumatica. CMAJ 186:E495–E501

    Article  PubMed  PubMed Central  Google Scholar 

  16. Pujades-Rodriguez M, Duyx B, Thomas SL et al (2016) Association between polymyalgia rheumatica and 12 cardiovascular diseases. Heart 102:383–389

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Collins T, Cybulsky MI (2001) MF-kB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107:255–264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Rajavashisth TB, Liao JK, Galis ZS et al (1999) Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1- matrix metalloproteinases. J Biol Chem 274:11924–11929

    Article  CAS  PubMed  Google Scholar 

  19. Jezovnik MK, Poredos P (2010) Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol 29:226–231

    CAS  PubMed  Google Scholar 

  20. Xu J, Lupu F, Esmon CT (2010) Inflammation, innate immunity and blood coagulation. Hamostaseologie 30(5–6):8–9

    Google Scholar 

  21. Ungprasert P, Srivali N, Spanuchart I et al (2014) Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol 33:297–304

    Article  PubMed  Google Scholar 

  22. Angelopoulos TP, Tentolouris NK, Bertsias GK et al (2014) Steroid-induced diabetes in rheumatologic patients. Clin Exp Rheumatol 32:126–130

    PubMed  Google Scholar 

  23. Doran MF, Crowson CS, O’Fallon WM et al (2002) Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota USA. J Rheumatol 29:1694–1697

    PubMed  Google Scholar 

  24. Boesen P, Sorensen SF (1987) Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982–1985. Arthritis Rheum 30:1739–1943

    Article  Google Scholar 

  25. Khan NF, Harrison SE, Rose PW et al (2010) Validity of diagnostic coding within the general practice research database: a systematic review. Br J Gen Pract 60:e128–e136

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Patompong Ungprasert, Matthew J. Koster, Kenneth J. Warrington & Eric L. Matteson

  2. Division of Rheumatology, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

    Patompong Ungprasert

  3. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA

    Eric L. Matteson

Authors
  1. Patompong Ungprasert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew J. Koster
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenneth J. Warrington
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eric L. Matteson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patompong Ungprasert.

Ethics declarations

Conflict of interest

All authors declare no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Not applicable (no human participants).

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 63 kb)

Supplementary material 2 (DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ungprasert, P., Koster, M.J., Warrington, K.J. et al. Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies. Rheumatol Int 37, 143–149 (2017). https://doi.org/10.1007/s00296-016-3557-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-016-3557-5

Keywords

Search

Navigation